ϟ
DOI: 10.1016/j.ejca.2017.05.033
OpenAccess: Closed
This work is not Open Acccess. We may still have a PDF, if this is the case there will be a green box below.
Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials
Dirk Schadendorf,Georgina V. Long,D. Stroiakovski,Bogusława Karaszewska,Axel Hauschild,Evgeny Levchenko,Vanna Chiarion-Sileni,Jacob Schachter,Claus Garbe,Caroline Dutriaux,Helen Gogas,Mario Mandalà,John B.A.G. Haanen,Célèste Lebbe,Andrzej Maćkiewicz,Piotr Rutkowski,Jean Jacques Grob,Paul Nathan,Antoni Ribas,Michael A. Davies,Ying Zhang,Mathilde Kaper,Bijoyesh Mookerjee,Jeffrey J. Legos,Keith T. Flaherty,Caroline Robert
Dabrafenib
Medicine
Trametinib
2017
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials” is a paper by Dirk Schadendorf Georgina V. Long D. Stroiakovski Bogusława Karaszewska Axel Hauschild Evgeny Levchenko Vanna Chiarion-Sileni Jacob Schachter Claus Garbe Caroline Dutriaux Helen Gogas Mario Mandalà John B.A.G. Haanen Célèste Lebbe Andrzej Maćkiewicz Piotr Rutkowski Jean Jacques Grob Paul Nathan Antoni Ribas Michael A. Davies Ying Zhang Mathilde Kaper Bijoyesh Mookerjee Jeffrey J. Legos Keith T. Flaherty Caroline Robert published in 2017. It has an Open Access status of “closed”. You can read and download a PDF Full Text of this paper here.